SCWorx (SCWorx) ROCE % : -52.93% (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is SCWorx ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SCWorx's annualized ROCE % for the quarter that ended in Sep. 2023 was -52.93%.

SCWorx ROCE % Historical Data

The historical data trend for SCWorx's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCWorx ROCE % Chart

SCWorx Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-134.44

-561.92

-93.33

-59.28

-30.91

SCWorx Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															-23.89	-30.96	-23.57	-8.86	-52.93

SCWorx ROCE % Calculation

SCWorx's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-2.127	/	( ( (9.123 - 2.284)	+	(9.247 - 2.323) )	/ 2 )
	=	-2.127	/	( (6.839	+	6.924)	/ 2 )
	=	-2.127	/	6.8815
	=	-30.91 %

SCWorx's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	-3.432	/	( ( (9.049 - 2.34)	+	(8.817 - 2.557) )	/ 2 )
	=	-3.432	/	( ( 6.709	+	6.26 )	/ 2 )
	=	-3.432	/	6.4845
	=	-52.93 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

SCWorx (NAS:WORX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SCWorx ROCE % Related Terms

Thank you for viewing the detailed overview of SCWorx's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

SCWorx (SCWorx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SCWorx Corp (NAS:WORX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

4R80:Germany

Address

590 Madison Avenue, 21st Floor, New York, NY, USA, 10022

Website

https://www.scworx.com

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics.

Executives

Vincent Michael Matozzo	director	412 RICHARD LANE, ORANGE CT 06477
Christopher John Kohler	officer: Chief Financial Officer	1149 CANTERBERRY LN, PARKER CO 80138
Steven Wallitt	director	C/O SCWORX CORP., 590 MADISON AVENUE, 21ST FLOOR, NEW YORK NY 10022
John C Ferrara	director	C/O EDGAR ONLINE, INC., 50 WASHINGTON STREET, NORWALK CT 06854
Steven Ross Horowitz	director	4 MELISSA COURT, MONTVILLE NJ 07045
Marc Sanford Schessel	director, 10 percent owner, officer: CEO	4 JACOBS LANE, NEW PALTZ NY 12561
Irby Alton F Iii	director	C/O MCKESSON CORP, ONE POST ST., SAN FRANCISCO CA 94104
Miller Charles Kenneth Iii	director	100 METROPLEX, EDISON NJ 08817
Timothy Andrew Hannibal	officer: President, COO	590 MADISON AVE, NEW YORK NY 10022
Mark Shefts	director	160 SUMMIT AVE, MONTVALE NJ 07645
John C Price	other: Former CFO	4721 IRONTON STREET, BUILDING A, DENVER CO 80239
Robert Steven Christie	director	34 SAN MARCO STREET, WEST WINDSOR NJ 08550
Ira E. Ritter	director	C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Knuettel Ii Francis	director	205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
James Thaddeus Schweikert	officer: Chief Operating Officer	7783 SOARING EAGLE CT., CINCINNATI OH 45244